NEOPLASMS, HEAD AND NECK
Clinical trials for NEOPLASMS, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, HEAD AND NECK trials appear
Sign up with your email to follow new studies for NEOPLASMS, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktails tested in battle against advanced head and neck cancer
Disease control OngoingThis study is testing new combinations of immunotherapy drugs for people with advanced head and neck cancer that has returned or spread. It aims to see if these new combinations work better and are as safe as a single existing immunotherapy drug. The trial will enroll about 316 a…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New cancer vaccine combo aims to outperform standard treatment in major trial
Disease control OngoingThis large, late-stage trial is testing whether adding an experimental immunotherapy called PDS0101 to the standard drug pembrolizumab (Keytruda) helps people with advanced HPV-positive head and neck cancer live longer. The study will enroll about 351 adults whose cancer has retu…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE3 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC